
BioMarin, founded in 1997, is a global biotechnology company that transforms lives through genetic discovery. The company focuses on developing targeted therapies that address the root causes of rare genetic diseases, bringing eight first-or best-in-class commercial treatments to market. Its pipeline features a portfolio of science-driven, patient-forward product candidates that expand treatment options across a broader spectrum of genetic disorders. BioMarin's distinctive approach combines rigorous research with a commitment to delivering innovative, life-changing therapies to patients worldwide.
The Executive Director, Global Health Economics and Outcomes Research will lead the global HEOR function, defining and executing integrated global evidence and value strategies across the full product lifecycle. This role reports to the SVP Global Head of Pricing, Access, Value and Evidence and is a member of PAVE leadership team.
BioMarin, founded in 1997, is a global biotechnology company that transforms lives through genetic discovery. The company focuses on developing targeted therapies that address the root causes of rare genetic diseases, bringing eight first-or best-in-class commercial treatments to market. Its pipeline features a portfolio of science-driven, patient-forward product candidates that expand treatment options across a broader spectrum of genetic disorders. BioMarin's distinctive approach combines rigorous research with a commitment to delivering innovative, life-changing therapies to patients worldwide.